Conquering Diseases

Investigational Study Of The Use Of Favipiravir In Hospitalized Subjects With Covid-19

Description

An investigational drug (Favipiravir) study for patients who have been hospitalized with the coronavirus COVID-19.

Overview

This study will compare the use of the investigational study drug (Favipiravir) with standard treatment vs standard treatment alone.

What we're hoping for

We are hoping to determine if the experimental drug is safe for use and helps people hospitalized with the COVID-19 coronavirus recover.

Additional Information

ClinicalTrials.gov Identifier: NCT04358549

 Principal Investigator

Robert  Finberg, MD

University of Massachusetts Medical School

 Study Contact

Jaclyn  Longtine

508-856-5472

Jaclyn.Longtine@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989